Search Results - "Valcárcel, David"

Long-Term Transfusion Independence with Luspatercept Versus Epoetin Alfa in Erythropoiesis-Stimulating Agent-Naive, Lower-Risk Myelodysplastic Syndromes in the COMMANDS Trial

Garcia-Manero, Guillermo^{Aff1, IDs12325025032085_cor1}, Santini, Valeria, Zeidan, Amer M., Komrokji, Rami S., Pozharskaya, Veronika, Rose, Shelonitda, Keeperman, Karen, Lai, Yinzhi, Kalsekar, Sameer, Aggarwal, Barkha, Miteva, Dimana, Valcárcel, David, Fenaux, Pierre, Shortt, Jake, Della Porta, Matteo Giovanni, Platzbecker, Uwe

Myelodysplastic neoplasms with ring sideroblasts without SF3B1 mutations in adults: enrichment of germline variants in congenital sideroblastic anemia genes: MYELODYSPLASTIC NEOPLASM

Novoa-Jáuregui, Sandra^{Aff1, Aff2}, Huber, Sandra, Gabarrós-Subirà, Maria, Chen-Liang, Tzu Hua, Torres-Esquius, Sara, Carrillo-Tornel, Salvador, Santiago, Marta, Bernal del Castillo, Teresa, Martín-Castillo, Iván, Hernandez, Francisca Maria, del Rey, Mónica, Liquori, Alessandro, Tormo, Mar, Cervera, Jose, Bosch, Francesc^{Aff1, Aff2}, Valcárcel, David^{Aff1, Aff2}, Haferlach, Claudia, Díez-Campelo, María, Montoro, María Julia^{Aff1, Aff2, IDs4137502502629z_cor1}, Haferlach, Torsten, Jerez, Andrés

Stroke, idiopathic thrombocytopenic purpura and avatrombopag: two cases of coincident events

Boy, Bernat, Iacoboni, Gloria, Valcárcel, David, Molina, Carlos^{Aff3, Aff4}, Rodrigo-Gisbert, Marc^{Aff3, Aff4, IDs10072025081868_cor1}

Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC

Escamilla-Gómez, Virginia^Aff1, García Gutiérrez, Valentín^{Aff2, IDs41409024024830_cor1}, Alcalde-Mellado, Patricia, Astibia-Mahillo, Beatriz, Chinea-Rodriguez, Anabelle, López-Corral, Lucía, Acera-Gómez, Marina, Torres Ochando, Melissa Karina, Borrero Borrego, Asunción, González Pinedo, Leslie, Zudaire Ripa, Teresa, González Vicent, Marta, Benzaquén, Ana, Izquierdo Garcia, Isabel, Asensi Cantó, Pedro, Montoro, Juan, Martín-Domínguez, Francisco Manuel, Orti, Guillermo, Valcárcel, David, Benitez-Carabante, Maria Isabel, Diaz-de-Heredia, Cristina, Cañamero, Eloi, Ferrá, Christelle, García-Cadenas, Irene, Redondo, Sara, Sisinni, Luisa, Perez-Martínez, Antonio, Mussetti, Alberto, Garcia-Mañó, Lucía, Palomo-Moraleda, María Del Pilar, González-Sierra, Pedro Antonio, Jurado, Manuel, Perez-Simon, Jose A.^{Aff1, IDs41409024024830_cor2}

Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies

Fox, Maria Laura^{Aff1, IDs41409024023222_cor1}, García-Cadenas, Irene^{Aff2, Aff3}, Navarro, Victor, Martínez, Ariadna Pérez, Kara, Meriem, Bazán, Irene Sánchez, Ferra Coll, Christelle, Bailén, Rebeca, Bento, Leyre, Parody, Rocío, Esquirol, Albert^{Aff2, Aff3}, Ortí, Guillermo, Mussetti, Alberto^{Aff6, Aff7, Aff8, Aff9, Aff10, Aff11}, Salamero, Olga, Martino, Rodrigo^{Aff2, Aff3}, González, Ana Pérez, Barba, Pere, Kwon, Mi, Solano, Carlos^{Aff5, Aff6, Aff7, Aff8, Aff9, Aff10, Aff11, Aff12}, Bosch, Francesc, Valcárcel, David

Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS

DeZern, Amy E. ^{1, ∗}, Thepot, Sylvain ², de Botton, Stephane ³, Patriarca, Andrea ⁴, Deeren, Dries ⁵, Torregrossa-Diaz, Jose-Miguel ⁶, Marconi, Giovanni ⁷, Bernal, Teresa ⁸, Bergua Burgues, Juan ⁹, Xicoy, Blanca ¹⁰, Jonášová, Anna ¹¹, Zeidan, Amer M. ¹², Dimicoli-Salazar, Sophie ¹³, Simand, Célestine ¹⁴, Valcarcel, David ¹⁵, Diez Campelo, Maria ¹⁶, Chai-Ho, Wanxing ¹⁷, Saini, Lalit ¹⁸, Garnier, Alice ¹⁹, Geissler, Klaus ²⁰, Ofran, Yishai ²¹, Nagy, Zsolt ²², Krishnamurthy, Pramila ²³, Lübbert, Michael ²⁴, Basak, Grzegorz ²⁵, Carraway, Hetty E. ²⁶, Sallman, David A. ²⁷, Borate, Uma ²⁸, Santini, Valeria ²⁹, Campbell, Victoria ³⁰, Fenaux, Pierre ³¹, Braun, Thorsten ³², Lanza, Francesco ³³, Zaucha, Jan Maciej ³⁴, Roth, David A. ³⁵, Paul, Sofia ³⁵, Roy, Pourab ³⁵, Kelly, Michael J. ³⁵, Volkert, Angela ³⁵, Chisholm, Jaime ³⁵, Malak, Tanya Abdul ³⁵, Klimek, Virginia M. ³⁵, Cluzeau, Thomas ³⁶

Graft Failure

Valcárcel, David^Aff6, Sánchez-Ortega, Isabel^Aff7, Sureda, Anna^Aff8

Sureda, Anna, editor^Aff1, Corbacioglu, Selim, editor^Aff2, Greco, Raffaella, editor^Aff3, Kröger, Nicolaus, editor^Aff4, Carreras, Enric, editor^Aff5

Selection of Stem Cell Source

Horgan, Claire^Aff6, Valcárcel, David^Aff7

Sureda, Anna, editor^Aff1, Corbacioglu, Selim, editor^Aff2, Greco, Raffaella, editor^Aff3, Kröger, Nicolaus, editor^Aff4, Carreras, Enric, editor^Aff5

Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial

Cabrero, Mónica^{Aff1, IDs41409023021715_cor1}, López-Corral, Lucia, Jarque, Isidro, de la Cruz-Vicente, Fátima, Pérez- López, Estefanía, Valcárcel, David, Sanz, Jaime, Espigado, Ildefonso, Ortí, Guillermo, Martín- Calvo, Carmen, de la Serna, Javier, Caballero, Dolores

Influence of TP53 gene mutations and their allelic status in myelodysplastic syndromes with isolated 5q deletion

Montoro, Maria Julia, Palomo, Laura, Haferlach, Claudia, Acha, Pamela, Chan, Onyee, Navarro, Víctor, Kubota, Yasuo, Schulz, Felicitas Isabel, Meggendorfer, Manja, Briski, Robert, Al Ali, Najla, Xicoy, Blanca, López-Cadenas, Félix, Bosch, Francesc, González, Teresa, Eder, Lea Naomi, Jerez, Andrés, Wang, Yu-Hung, Campagna, Alessia, Santini, Valeria, Bernal del Castillo, Teresa, Such, Esperanza, Tien, Hwei-Fang, Diaz Varela, Nicolás, Platzbecker, Uwe, Haase, Detlef, Díez-Campelo, María, Della Porta, Matteo, Garcia-Manero, Guillermo, Wiseman, Daniel H., Germing, Ulrich, Maciejewski, Jaroslaw P., Komrokji, Rami S., Sole, Francesc, Haferlach, Torsten, Valcárcel, David

Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial

Della Porta, Matteo Giovanni ^{*, *}, Garcia-Manero, Guillermo ^*, Santini, Valeria, Zeidan, Amer M, Komrokji, Rami S, Shortt, Jake, Valcárcel, David, Jonasova, Anna, Dimicoli-Salazar, Sophie, Tiong, Ing Soo, Lin, Chien-Chin, Li, Jiahui, Zhang, Jennie, Pilot, Richard, Kreitz, Sandra, Pozharskaya, Veronika, Keeperman, Karen L, Rose, Shelonitda, Prebet, Thomas, Lai, Yinzhi, Degulys, Andrius, Paolini, Stefania, Cluzeau, Thomas, Fenaux, Pierre ^†, Platzbecker, Uwe ^†

Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

Zugasti, Ines^{Aff1, Aff10, Aff12}, Lopez-Guerra, Monica^{Aff1, Aff11, Aff13}, Castaño-Díez, Sandra^{Aff1, Aff10, Aff11}, Esteban, Daniel^{Aff1, Aff7, Aff11}, Avendaño, Alejandro^{Aff2, Aff10}, Pomares, Helena^{Aff3, Aff10}, Perez, Ana^{Aff4, Aff10}, García-Ávila, Sara^{Aff5, Aff10}, Conejo, Irene Padilla^{Aff6, Aff10}, de la Fuente Montes, Cristina^{Aff7, Aff10}, Martínez-Roca, Alexandra^{Aff1, Aff11}, Merchán, Beatriz^{Aff1, Aff11}, Jiménez-Vicente, Carlos^{Aff1, Aff11}, Guijarro, Francesca^{Aff1, Aff11}, Álamo, Jose Ramón^{Aff1, Aff11}, Cortes-Bullich, Albert^{Aff1, Aff11}, Torrecillas, Victor, Mont, Lucia, Carcelero, Esther, Riu, Gisela, Zamora, Lurdes^{Aff7, Aff14}, Bargay, Joan, Triguero, Ana^{Aff1, Aff11}, Suarez-Lledó, Maria^{Aff1, Aff11}, Salas, Maria Queralt^{Aff1, Aff11}, López-Cadenas, Felix^{Aff5, Aff10}, Ramos, Fernando^{Aff6, Aff10}, Xicoy, Blanca^{Aff7, Aff10, Aff12, Aff14}, Valcárcel, David^{Aff4, Aff10}, Arnan, Montserrat^{Aff3, Aff10}, Martínez, Carmen^{Aff1, Aff11}, Rovira, Montserrat^{Aff1, Aff11}, Fernández-Avilés, Francesc^{Aff1, Aff11}, Díez-Campelo, Maria^{Aff2, Aff10}, Esteve, Jordi^{Aff1, Aff11, Aff12}, Díaz-Beyá, Marina^{Aff1, Aff10, Aff11, Aff12, IDs40164025006525_cor1}

This result is not displayed to guests.
Login for full access.

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial

Platzbecker, Uwe ^{*, *}, Santini, Valeria ^*, Fenaux, Pierre, Sekeres, Mikkael A, Savona, Michael R, Madanat, Yazan F, Díez-Campelo, Maria, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Bělohlávková, Petra, Sherman, Laurie J, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Xia, Qi, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Feller, Faye, Komrokji, Rami S, Zeidan, Amer M

Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes

Haque, Tamanna, Cadenas, Felix López, Xicoy, Blanca, Alfonso-Pierola, Ana, Platzbecker, Uwe, Avivi, Irit, Brunner, Andrew M., Chromik, Jöerg, Morillo, Daniel, Patel, Manish R., Falantes, Jose, Leitch, Heather A., Germing, Ulrich, Preis, Meir, Lenox, Laurie, Lauring, Josh, Brown, Regina J., Kalota, Anna, Mehta, Jaydeep, Pastore, Friederike, Gu, Junchen, Mistry, Pankaj, Valcárcel, David

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

Platzbecker, Uwe ^{*, *}, Della Porta, Matteo Giovanni ^*, Santini, Valeria, Zeidan, Amer M, Komrokji, Rami S, Shortt, Jake, Valcarcel, David, Jonasova, Anna, Dimicoli-Salazar, Sophie, Tiong, Ing Soo, Lin, Chien-Chin, Li, Jiahui, Zhang, Jennie, Giuseppi, Ana Carolina, Kreitz, Sandra, Pozharskaya, Veronika, Keeperman, Karen L, Rose, Shelonitda, Shetty, Jeevan K, Hayati, Sheida, Vodala, Sadanand, Prebet, Thomas, Degulys, Andrius, Paolini, Stefania, Cluzeau, Thomas, Fenaux, Pierre ^†, Garcia-Manero, Guillermo ^†

Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

Izquierdo, Cristina Pascual, Mingot-Castellano, María Eva ^∗, Fuentes, Ana E. Kerguelen, García-Arroba Peinado, José, Cid, Joan, Jimenez, Maria Moraima, Valcarcel, David, Gómez-Seguí, Inés, de la Rubia, Javier, Martin, Paz, Goterris, Rosa, Hernández, Luis, Tallón, Inmaculada, Varea, Sara, Fernández, Marta, García-Muñoz, Nadia, Vara, Míriam, Zarzoso, Miguel Fernández, García-Candel, Faustino, Paciello, María Liz, García-García, Irene, Zalba, Saioa, Campuzano, Verónica, Gala, José María, Estévez, Julia Vidán, Jiménez, Gemma Moreno, López Lorenzo, José Luis, Arias, Elena González, Freiría, Carmen, Solé, María, Ávila Idrovo, Laura Francisca, Hernández Castellet, José Carlos, Cruz, Naylen, Lavilla, Esperanza, Pérez-Montaña, Albert, Atucha, Jon Ander, Moreno Beltrán, María Esperanza, Moreno Macías, Juán Ramón, Salinas, Ramón, del Rio-Garma, Julio

Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study

Aiuti, Alessandro, Maschan, Alexei, Aljurf, Mahmoud, Gedde-Dahl, Tobias, Gurman, Gunhan, Bordon, Victoria, Kriván, Gergely, Locatelli, Franco, Porta, Fulvio, Valcárcel, David, Beguin, Yves, Faraci, Maura, Kröger, Nicolaus, Kulagin, Aleksandr, Shaw, Peter J., Veelken, Joan Hendrik, Diaz de Heredia, Cristina, Fagioli, Franca, Felber, Matthias, Gruhn, Bernd, Holter, Wolfgang, Rössig, Claudia, Sedlacek, Petr, Apperley, Jane, Ayas, Mouhab, Bodova, Ivana, Choi, Goda, Cornelissen, J.J., Sirvent, Anne, Khan, Anjum, Kupesiz, Alphan, Lenhoff, Stig, Ozdogu, Hakan, von der Weid, Nicolas, Rovira, Montserrat, Schots, Rik, Vinh, Donald C., Albert, Michael H., Sirait, Tiarlan, Eikema, Dirk-Jan, Bakunina, Katerina, Wehr, Claudia, Suarez, Felipe, Fox, Maria Laura, Mahlaoui, Nizar, Gennery, Andrew R., Lankester, Arjan C., Beier, Rita, Bernardo, Maria Ester, Bigley, Venetia, Lindemans, Caroline A., Burns, Siobhan O., Carpenter, Ben, Dybko, Jaroslaw, Güngör, Tayfun, Hauck, Fabian, Lum, Su Han, Balashov, Dmitry, Meisel, Roland, Moshous, Despina, Schulz, Ansgar, Speckmann, Carsten, Slatter, Mary A., Strahm, Brigitte, Uckan-Cetinkaya, Duygu, Meyts, Isabelle, Vallée, Tanja C., Wynn, Robert, Neven, Bénédicte, Morris, Emma C.

Pevonedistat plus azacitidine vs azacitidine alone in higher-risk MDS/chronic myelomonocytic leukemia or low-blast-percentage AML

Adès, Lionel ^*, Girshova, Larisa, Doronin, Vadim A., Díez-Campelo, María, Valcárcel, David, Kambhampati, Suman, Viniou, Nora-Athina, Woszczyk, Dariusz, De Paz Arias, Raquel, Symeonidis, Argiris, Anagnostopoulos, Achilles, Munhoz, Eduardo Ciliao, Platzbecker, Uwe, Santini, Valeria, Fram, Robert J., Yuan, Ying, Friedlander, Sharon, Faller, Douglas V., Sekeres, Mikkael A.

Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan

Guijarro, Francesca, Bataller, Alex^{Aff1, Aff2}, Diaz-Beyá, Marina^{Aff1, Aff2}, Garrido, Ana^{Aff2, Aff3}, Coll-Ferrà, Christelle^{Aff2, Aff4, Aff5}, Vives, Susana^{Aff2, Aff4, Aff6}, Salamero, Olga, Valcárcel, David, Tormo, Mar, Arnan, Montserrat, Sampol, Antònia, Castaño-Díez, Sandra, Martínez, Carmen^{Aff1, Aff2, Aff11}, Suárez-Lledó, María^{Aff1, Aff2}, Fernández-Avilés, Francesc^{Aff1, Aff2}, Hernández-Boluda, Juan Carlos, Ribera, Josep Maria^{Aff2, Aff4, Aff6}, Rovira, Montserrat^{Aff1, Aff2, Aff11}, Brunet, Salut^{Aff2, Aff3, Aff6}, Sierra, Jorge^{Aff2, Aff3, Aff6}, Esteve, Jordi^{Aff1, Aff2, Aff11, IDs41409022017039_cor21}